Product
INCA034176
Aliases
Axatilimab
1 clinical trial
1 indication
Indication
Chronic Graft-versus-host diseaseClinical trial
A Phase 3, Open-Label, Multicenter Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Axatilimab Monotherapy in Japanese Participants With Recurrent or Refractory Active Chronic Graft-Versus-Host Disease After at Least 2 Lines of Systemic TherapyStatus: Not yet recruiting, Estimated PCD: 2025-12-31